• Return to Headlines

Shares of Regeneron Pharm Has Fallen Below Previous 52-Week Low

By David Diaz

Regeneron Pharm (NASDAQ:REGN) traded today at a new 52-week low of $275.69. Approximately 232,000 shares have changed hands today, as compared to an average 30-day volume of 660,000 shares.

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron Pharmaceuticals serves the healthcare sector in the United States.

Potential upside of 33.7% exists for Regeneron Pharm, based on a current level of $275.69 and analysts' average consensus price target of $368.55. The stock should run into initial resistance at its 50-day moving average (MA) of $300.12 and subsequent resistance at its 200-day MA of $353.22.

Regeneron Pharm share prices have moved between a 52-week high of $445.00 and the current low of $275.69 and are currently at $275.69 per share. The 200-day and 50-day moving averages have moved 0.3% lower and 0.65% lower over the past week, respectively.

SmarTrend recommended that its subscribers protect gains by selling shares of Regeneron Pharm on July 11th, 2019 by issuing a Downtrend alert when the shares were trading at $292.49. Since that call, shares of Regeneron Pharm have fallen 4.6%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows regeneron pharm

Ticker(s): REGN